UnknownPhase 2NCT00003758

Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia

Studying Acute basophilic leukemia

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Principal Investigator: Petra Muus, MD, PhD, MD
Universitair Medisch Centrum St. Radboud - Nijmegen
Intervention: cytarabine(drug)
Enrollment: 60 enrolled
Eligibility: 15-60 years · All sexes
Timeline: 1998

Study locations (16)

Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
A.Z. St. Jan, Bruges, Belgium
Institut Jules Bordet, Brussels, Belgium
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
Medical School/University of Zagreb, Zagreb, Croatia
University Hospital Rebro, Zagreb, Croatia
Hotel Dieu de Paris, Paris, France
Hopital Necker, Paris, France
Ospedale San Eugenio, Rome, Italy
Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore, Rome, Italy
Groot Ziekengasthuis 's-Hertogenbosch, 's-Hertogenbosch, Netherlands
Leiden University Medical Center, Leiden, Netherlands
University Medical Center Nijmegen, Nijmegen, Netherlands
Sint Joseph Ziekenhuis, Veldhoven, Netherlands
Hospital Escolar San Joao, Porto, Portugal
+1 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00003758 on ClinicalTrials.gov

Other trials for Acute basophilic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute basophilic leukemia →

← Back to all trials